| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032845 1,1-and 1,2-disubstituted cyclopropane compounds |
| 02/10/2005 | US20050032828 E. g., 4-[3-Isopropyl-3-(2-mercapto-benzothiazol-6-yl)-ureido]-piperidine-1-carboxylic acid benzyl ester; metabolic diseases; management/treatment glucose/fatty acid pathway; cardiovascular disorders; congestive heart failure; angina pectoris; antidiabetic agent, anticarcinogenic agents; obesity |
| 02/10/2005 | US20050032824 E. g., 1-Cyano-3-(2-mercaptobenzothiazol-6-yl)-2-phenylisourea; metabolic diseases; management of the glucose/fatty acid pathway; antilipemic agents; cardiovascular diseases; antidiabetic agents; anticarcinogenic agents; obesity; more profound effects in metabolism shift than ranolazine or trimetazidine |
| 02/10/2005 | US20050032809 5-HT receptor ligands and uses thereof |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032798 Diaryl ureas, which release urea compound when administered to patient, for example, 1-(4-chloro-3(trifluoromethyl)phenyl)-3-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)-2-oxo-(1,3,5-perhydrotriazapine); treatment of cancer, inflammation |
| 02/10/2005 | US20050032793 For example, 1,1-dimethylethyl [2-[[2-(diethylamino)-2-oxo-1S-(phenylmethyl)ethyl]amino]-5-methyl-4-oxo-4H-3,1-benzoxazin-6-yl]carbamate; for treating herpes-related disorders |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032791 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050032788 treating fibrotic lung diseases and fibrotic hypertrophy or fibrosis of prostate, liver, the pleura, pancreas or bowel wall with saturated and unsaturated azoles and salts, e.g., 3-[2-phenyl-2-oxoethyl]-4,5-dimethyl-thiazolium salt |
| 02/10/2005 | US20050032786 1, 3-benzothiazinone derivatives and use thereof |
| 02/10/2005 | US20050032775 Aztreonam L-lysine and methods for the preparation thereof |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | US20050031542 using carbocyanine dyes; photodynamic therapy; supplying to tumors |
| 02/10/2005 | US20050030912 Use of hybrid (HW/DSP/MCU/SW) architectures for powerline OFDM communication field |
| 02/10/2005 | DE3823105B4 Dolastatin 10, Verfahren zu seiner Gewinnung, und es enthaltende pharmazeutische Zusammensetzungen Dolastatin 10, process for its production, and pharmaceutical compositions containing it |
| 02/10/2005 | DE10331675A1 Hetarylsubstituierte Pyrazolidindion-Derivate Hetarylsubstituierte pyrazolidindione derivatives |
| 02/10/2005 | CA2534649A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | CA2534464A1 Benzoxazepine compound |
| 02/10/2005 | CA2534212A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | CA2533870A1 Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors |
| 02/10/2005 | CA2533824A1 Bicyclic compounds and compositions as pdf inhibitors |
| 02/10/2005 | CA2533673A1 Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same |
| 02/10/2005 | CA2533635A1 Novel 6-phenylphenantridines |
| 02/10/2005 | CA2533554A1 6-membered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 02/10/2005 | CA2533475A1 Neuroprotective benzo[1,3]oxathol-2-ones |
| 02/10/2005 | CA2532505A1 5-ht2b receptor antagonists |
| 02/10/2005 | CA2531140A1 2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors |
| 02/10/2005 | CA2520546A1 Benzo[1,2,5]thiadiazole compounds |
| 02/09/2005 | EP1505067A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism |
| 02/09/2005 | EP1503998A1 Heteroaryl substituted spirocyclic sufamides for inhibition of gamma secretase |
| 02/09/2005 | EP1503997A1 Cysteine protease inhibitors |
| 02/09/2005 | EP1503994A1 Substituted (thioxo)carbonylamino phenyl uraciles |
| 02/09/2005 | EP1503988A2 Fredericamycin derivatives |
| 02/09/2005 | EP1204322B1 Fungicides |
| 02/09/2005 | EP1105376B1 Oxindole derivatives as growth hormone releasers |
| 02/09/2005 | EP1087951B1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 02/09/2005 | CN1578910A Neurofibrillary labels |
| 02/09/2005 | CN1578786A Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1578665A Type 4 phosphodiesterase inhibitors and uses thereof |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1576275A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/09/2005 | CN1188411C Oxime derivatives and agricultural chemicals containing same |
| 02/09/2005 | CN1188410C Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the same inhibitor |
| 02/09/2005 | CN1188407C Imidazole derivatives with farnesyl transferase to inhibite activity and preparing method thereof |
| 02/09/2005 | CN1188404C Cyclic compound |
| 02/09/2005 | CN1188403C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/08/2005 | US6852752 Urea compounds, compositions and methods of use and preparation |
| 02/08/2005 | US6852745 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 02/08/2005 | US6852742 To modulate the activity of calcium channels, therapy of cardiovascular disease or neurological disorders, that are associated with calcium channels |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852720 Thiazol-2-yl-imine compounds as PDE-7 inhibitors |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/08/2005 | US6852714 (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | US6852548 Produce light energy when decomposed; stable at room temperature |
| 02/08/2005 | CA2112081C Imidazole compounds, their preparation and use |
| 02/03/2005 | WO2005010154A2 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 02/03/2005 | WO2005009999A1 Process for producing imide compound |
| 02/03/2005 | WO2005009998A1 Pna monomer and precursor |
| 02/03/2005 | WO2005009996A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 02/03/2005 | WO2005009995A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009994A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009988A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 02/03/2005 | WO2005009987A1 Piperidine compounds and pharmaceutical compositions containing them |
| 02/03/2005 | WO2005009982A2 Aryl-substituted benzo[d]isothiazol-3-ylamine analogues as capsaicin receptor modulators |
| 02/03/2005 | WO2005009978A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | WO2005009967A2 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/03/2005 | WO2005009964A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009962A1 Hydroxypyridine cgrp receptor antagonists |
| 02/03/2005 | WO2005009957A1 Tyrosine kinase inhibitors |
| 02/03/2005 | WO2005009950A2 Piperidine derivatives as melanocortin-4 receptor agonists |
| 02/03/2005 | WO2005009435A1 Aminopyrazole compounds and use as chk1 inhibitors |
| 02/03/2005 | WO2005009373A2 Tyrosine kinase inhibitors |
| 02/03/2005 | WO2004100998A3 Compositions and methods for non-invasive imaging of soluble beta-amyloid |
| 02/03/2005 | WO2004100881A3 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 02/03/2005 | US20050027125 Intensifiers of adenosine receptors for cardiac arrhythmia |
| 02/03/2005 | US20050027121 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 02/03/2005 | US20050027009 New derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/03/2005 | US20050026976 Isoindolinone kinase inhibitors |
| 02/03/2005 | US20050026973 New heterocyclic oxime compounds |
| 02/03/2005 | US20050026972 Benzimidazol-or indol-aminoacetonitrile derivatives for parasite control |
| 02/03/2005 | US20050026971 New effector conjugates, process for their production and their pharmaceutical use |
| 02/03/2005 | US20050026968 Heterocyclic amides with anti-tuberculosis activity |
| 02/03/2005 | US20050026966 Coupling a benzylcarbamate compound containing carboxylic group with an amine to form amide, deprotecting the amide to form free amine, reducing free amine, forming an amine salt with toulene sulfonic acid, coupling bis-toulenesulfonic acid salt with a thiazole derivative to form the end product |
| 02/03/2005 | US20050026963 Pyrazole substituted directly, or by a bridge, with a heteroaryl group containing N adjacent to the point of connection of the heteroaryl useful in the treatment of psychiatric and mood disorders such as, schizophrenia, anxiety, depression, bipolar disorder, circadian rhythm and sleep disorders |
| 02/03/2005 | US20050026952 Nicotinamide derivatives useful as PDE4 inhibitors |
| 02/03/2005 | US20050026945 Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors |
| 02/03/2005 | US20050026942 Chemokine receptor binding heterocyclic compounds |
| 02/03/2005 | US20050026930 1,3,4-Thiadiazole-2-sulfonyl-N-piperazine; 1,3,4-oxadiazole-2-sulfonyl-N-piperazine; oxazole-2-sulfonyl-N-piperazine; or thiazole-2-sulfonyl-N-piperazine derivatives; cyclization, coupling, amidation; peptide synthesis; peptide nucleic acids |
| 02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
| 02/03/2005 | US20050026927 Pyrazole derivatives as psychopharmaceuticals |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | US20050026914 Pyrimidine or pyridine carbamate compounds as for example 1,1-dimethylethyl 4-(4-((4-((((2,6-dimethylphenyl)oxy)carbonyl)(4-(methyloxy)phenyl)amino)-2-pyrimidinyl)amino)phenyl)-1-piperazinecarboxylate; for the treatment of protein tyrosine kinase-associated disorders |
| 02/03/2005 | US20050026913 N-substituted aniline and diphenylamine analogs; exhibit improved PDE4 inhibition; novel rolipram analogs which facilitate entry into cells, especially cells of the nervous system |